SC
IDYA icon

Stephens Consulting’s IDEAYA Biosciences IDYA Stock Holding History

Stephens Consulting’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20
Closed -$328 – 1563
2025
Q1 		$328 Buy
+20
New +$426 ﹤0.01% 1423

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Stephens Consulting's IDYA Position: Q2 2025 in Review

Stephens Consulting sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 20 shares — an estimated $328 sold.

Stephens Consulting first reported a position in IDYA in Q1 2025 and held it in 1 quarter. The position peaked at $328 in Q1 2025. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • Stephens Consulting reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 20 IDEAYA Biosciences shares in Q2 2025, an estimated $328.
  • Stephens Consulting first reported a position in IDEAYA Biosciences in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's IDEAYA Biosciences position peaked at $328 in Q1 2025.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.